Xiangning Yuan

1.3k total citations · 1 hit paper
26 papers, 895 citations indexed

About

Xiangning Yuan is a scholar working on Nephrology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiangning Yuan has authored 26 papers receiving a total of 895 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Nephrology, 7 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiangning Yuan's work include Chronic Kidney Disease and Diabetes (8 papers), Renal Diseases and Glomerulopathies (4 papers) and Inflammasome and immune disorders (4 papers). Xiangning Yuan is often cited by papers focused on Chronic Kidney Disease and Diabetes (8 papers), Renal Diseases and Glomerulopathies (4 papers) and Inflammasome and immune disorders (4 papers). Xiangning Yuan collaborates with scholars based in China, Canada and United States. Xiangning Yuan's co-authors include Qiongjing Yuan, Xiangcheng Xiao, Tianci Deng, Xiufen Wang, Huipeng Ge, Gong Xiao, Chengzhi Wang, Lijian Tao, Jie Meng and Zhangzhe Peng and has published in prestigious journals such as PLoS ONE, The FASEB Journal and Frontiers in Immunology.

In The Last Decade

Xiangning Yuan

24 papers receiving 855 citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The epidemiology and clinical information about COVID-19

2020 440 citations Huipeng Ge, Xiufen Wang et al. European Journal of Clinical Microbiology & Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiangning Yuan China	14	246	217	140	112	95	26	895
Xianghong Yang China	17	356 1.4×	188 0.9×	116 0.8×	158 1.4×	144 1.5×	44	931
Iziah E Sama Netherlands	16	245 1.0×	111 0.5×	89 0.6×	97 0.9×	126 1.3×	25	950
Jae Won Yang South Korea	16	288 1.2×	217 1.0×	81 0.6×	136 1.2×	138 1.5×	75	1.2k
Yahya Mahamat‐Saleh France	18	222 0.9×	110 0.5×	141 1.0×	134 1.2×	153 1.6×	41	1.1k
Qiongjing Yuan China	22	253 1.0×	411 1.9×	187 1.3×	115 1.0×	137 1.4×	57	1.4k
Zhonglin Chai Australia	20	441 1.8×	365 1.7×	92 0.7×	205 1.8×	195 2.1×	52	1.6k
Joyce Zhou United States	18	518 2.1×	325 1.5×	87 0.6×	220 2.0×	170 1.8×	37	1.5k
Xiangcheng Xiao China	20	274 1.1×	405 1.9×	320 2.3×	129 1.2×	147 1.5×	71	1.4k
Laurent Chouchana France	17	270 1.1×	168 0.8×	90 0.6×	66 0.6×	130 1.4×	77	998

Countries citing papers authored by Xiangning Yuan

Since Specialization

Citations

This map shows the geographic impact of Xiangning Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangning Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangning Yuan more than expected).

Fields of papers citing papers by Xiangning Yuan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangning Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangning Yuan. The network helps show where Xiangning Yuan may publish in the future.

Co-authorship network of co-authors of Xiangning Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangning Yuan. A scholar is included among the top collaborators of Xiangning Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangning Yuan. Xiangning Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yuan, Xiangning, Tong Li, Yudong Liu, et al.. (2025). Efficacy and safety of belimumab versus rituximab for refractory immune thrombocytopenia in patients with connective tissue disease. Lupus Science & Medicine. 12(1). e001501–e001501.

Li, Enhui, Linlin Zhang, Huipeng Ge, et al.. (2025). Continuous Renal Replacement Therapy Versus Intermittent Hemodialysis for Renal Prognosis in Elderly Patients With Acute Kidney Injury. International Journal of Nephrology. 2025(1). 8899604–8899604.

Jiang, Li, et al.. (2024). MYELOID-DERIVED TLR4-TRIF SIGNALING PATHWAY MEDIATES OXIDATIVE STRESS IN LPS/D-GALN-INDUCED ACUTE LIVER FAILURE. Shock. 62(4). 582–587. 2 indexed citations

Zhang, Weiwei, Leping Liu, Xiangcheng Xiao, et al.. (2023). Identification of common molecular signatures of SARS-CoV-2 infection and its influence on acute kidney injury and chronic kidney disease. Frontiers in Immunology. 14. 961642–961642. 11 indexed citations

Fan, Fan, et al.. (2023). Chronic kidney disease as a predictive factor for poor prognosis in traumatic brain injury among older adults: a case-control study. Frontiers in Neurology. 14. 1286592–1286592. 1 indexed citations

Liao, Xiaohua, Xin Lv, Yan Zhang, et al.. (2022). Fluorofenidone Inhibits UUO/IRI‐Induced Renal Fibrosis by Reducing Mitochondrial Damage. Oxidative Medicine and Cellular Longevity. 2022(1). 2453617–2453617. 22 indexed citations

Wang, Fangyuan, et al.. (2021). Altered circulating CCR6+and CXCR3+ T cell subsets are associated with poor renal prognosis in MPO-ANCA-associated vasculitis. Arthritis Research & Therapy. 23(1). 194–194. 6 indexed citations

Yuan, Xiangning, Wenbin Tang, Ling Peng, et al.. (2021). Elevation of LncRNA ENST00000453774.1 Prevents Renal Fibrosis by Upregulating FBN1, IGF1R, and KLF7. Kidney & Blood Pressure Research. 46(5). 563–573. 2 indexed citations

Xiao, Gong, Qiongjing Yuan, Xiangning Yuan, et al.. (2021). Long Non-coding RNA ENST00000453774.1 Confers an Inhibitory Effect on Renal Fibrosis by Inhibiting miR-324-3p to Promote NRG1 Expression. Frontiers in Cell and Developmental Biology. 9. 580754–580754. 9 indexed citations

10.

Tu, Sha, Yanzhi Jiang, Xiangning Yuan, et al.. (2021). Fluorofenidone protects liver against inflammation and fibrosis by blocking the activation of NF‐κB pathway. The FASEB Journal. 35(7). e21497–e21497. 18 indexed citations

11.

Dai, Qin, Yan Zhang, Xiaohua Liao, et al.. (2020). Fluorofenidone Alleviates Renal Fibrosis by Inhibiting Necroptosis Through RIPK3/MLKL Pathway. Frontiers in Pharmacology. 11. 534775–534775. 26 indexed citations

12.

Yuan, Qiongjing, Haixia Zhang, Tianci Deng, et al.. (2020). Role of Artificial Intelligence in Kidney Disease. International Journal of Medical Sciences. 17(7). 970–984. 44 indexed citations

13.

Xu, Hui, Xiaozhao Li, Xiangning Yuan, et al.. (2020). A meta-analysis of the clinical efficacy and safety of Bailing capsules in the treatment of nephrotic syndrome. Annals of Palliative Medicine. 9(5). 3170–3181. 7 indexed citations

14.

Ge, Huipeng, Xiufen Wang, Xiangning Yuan, et al.. (2020). The epidemiology and clinical information about COVID-19. European Journal of Clinical Microbiology & Infectious Diseases. 39(6). 1011–1019. 440 indexed citations breakdown →

15.

Wang, Yu, Wenbin Tang, Xiangning Yuan, et al.. (2019). Involvement of hydrogen sulfide in the progression of renal fibrosis. Chinese Medical Journal. 132(23). 2872–2880. 22 indexed citations

16.

Yuan, Xiangning, Jin Zhang, Feifei Xie, et al.. (2017). Loss of the Protein Cystathionine β-Synthase During Kidney Injury Promotes Renal Tubulointerstitial Fibrosis. Kidney & Blood Pressure Research. 42(3). 428–443. 22 indexed citations

17.

Zhang, Jin, Linfeng Zheng, Xiangning Yuan, et al.. (2016). Mefunidone ameliorates renal inflammation and tubulointerstitial fibrosis via suppression of IKKβ phosphorylation. The International Journal of Biochemistry & Cell Biology. 80. 109–118. 18 indexed citations

18.

Lu, Miaomiao, Wenjun Yang, Zhangzhe Peng, et al.. (2015). Fluorofenidone inhibits macrophage IL-1β production by suppressing inflammasome activity. International Immunopharmacology. 27(1). 148–153. 15 indexed citations

19.

Mei, Wenjuan, Zhangzhe Peng, Miaomiao Lu, et al.. (2015). Peroxiredoxin 1 inhibits the oxidative stress induced apoptosis in renal tubulointerstitial fibrosis. Nephrology. 20(11). 832–842. 31 indexed citations

20.

Mei, Wenjuan, Yanyun Xie, Jishi Liu, et al.. (2014). Fluorofenidone Offers Improved Renoprotection at Early Interventions during the Course of Diabetic Nephropathy in db/db Mice via Multiple Pathways. PLoS ONE. 9(10). e111242–e111242. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact